Nations Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
4,216
+174
| +4% | +$77.5K | 0.13% | 188 |
|
|
2025
Q1 | $1.96M | Buy |
4,042
+74
| +2% | +$35.9K | 0.15% | 166 |
|
|
2024
Q4 | $1.6M | Sell |
3,968
-13
| -0.3% | -$5.24K | 0.12% | 202 |
|
|
2024
Q3 | $1.85M | Buy |
3,981
+226
| +6% | +$105K | 0.13% | 177 |
|
|
2024
Q2 | $1.76M | Sell |
3,755
-33
| -0.9% | -$15.5K | 0.14% | 165 |
|
|
2024
Q1 | $1.58M | Buy |
3,788
+468
| +14% | +$196K | 0.13% | 178 |
|
|
2023
Q4 | $1.35M | Buy |
3,320
+45
| +1% | +$18.3K | 0.13% | 191 |
|
|
2023
Q3 | $1.14M | Buy |
3,275
+145
| +5% | +$50.4K | 0.11% | 211 |
|
|
2023
Q2 | $1.1M | Buy |
3,130
+16
| +0.5% | +$5.63K | 0.11% | 221 |
|
|
2023
Q1 | $981K | Buy |
3,114
+87
| +3% | +$27.4K | 0.1% | 231 |
|
|
2022
Q4 | $874K | Sell |
3,027
-155
| -5% | -$44.8K | 0.1% | 242 |
|
|
2022
Q3 | $921K | Sell |
3,182
-744
| -19% | -$215K | 0.13% | 187 |
|
|
2022
Q2 | $1.11M | Buy |
3,926
+113
| +3% | +$31.8K | 0.15% | 170 |
|
|
2022
Q1 | $995K | Buy |
3,813
+1,365
| +56% | +$356K | 0.12% | 193 |
|
|
2021
Q4 | $538K | Buy |
+2,448
| New | +$538K | 0.07% | 283 |
|
|
2020
Q4 | – | Sell |
-1,526
| Closed | -$415K | – | 319 |
|
|
2020
Q3 | $415K | Buy |
+1,526
| New | +$415K | 0.13% | 194 |
|